Advertisement

Protective effect of puerarin on diabetic retinopathy in rats

  • Yan Teng
  • Hao Cui
  • Mingming Yang
  • Han Song
  • Qingsheng Zhang
  • Ying Su
  • Jianqiu Zheng
Article

Abstract

Puerarin is a major active ingredient extracted from the traditional Chinese medicine Ge-gen. The purpose of this study is to investigate the protective effect of puerarin on diabetic retinopathy (DR) and its mechanisms in rats. Seventy-two male Wistar rats were selected and divided at random into three main groups: control group, streptozotocin (STZ) group and puerarin + STZ group. Retinal histopathological observation and electron microscopic examination were performed; retinal vascular endothelial growth factor (VEGF) and hypoxia inducible factor 1 (HIF-1α) gene expressions were examined by Reverse transcription-polymerase chain reaction (RT-PCR) analysis. Results showed that the DR induced by STZ was significantly reduced by the treatment of puerarin as judged by the reduction of morphological changes of inner nuclear layer and outer nuclear layer at any time-point. Puerarin regulates expressions of VEGF and HIF-1α stimulated by STZ. It was concluded that puerarin exerts significant protective effects against DR in rats, likely regulating angiogenesis factors expressions, and thus may be an effective and promising medicine for treatment of DR.

Keywords

Diabetic retinopathy Vascular growth factor Puerarin 

References

  1. 1.
    Sato S, Yamamoto T, Yamashita H (2006) Diabetic retinopathy-state of arts of diagnosis and treatment. Nippon Rinsho Suppl 3:161–168PubMedGoogle Scholar
  2. 2.
    Moss SE, Klein R, Klein BE (1998) The 14-year incidence of visual loss in a diabetic population. Ophthalmology 105:998–1003. doi: 10.1016/S0161-6420(98)96025-0 PubMedCrossRefGoogle Scholar
  3. 3.
    Tolentino MJ, Miller JW, Gragoudas ES, Jakobiec FA, Flynn E, Chatzistefanou K et al (1996) Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 103:1820–1828PubMedGoogle Scholar
  4. 4.
    Cherdshewasart W, Subtang S, Dahlan W (2007) Major isoflavonoid contents of the phytoestrogen rich-herb Pueraria mirifica in comparison with Pueraria lobata. J Pharm Biomed Anal 43:428–434. doi: 10.1016/j.jpba.2006.07.013 PubMedCrossRefGoogle Scholar
  5. 5.
    Kirakosyan A, Kaufman PB, Warber S, Bolling S, Chang S, Duke JA (2003) Quantification of major isoflavonoids and l-canavanine in several organs of Kudzu vine (Pueraria lobata) and in starch samples derived from Kudzu roots. Plant Sci 164:883–888. doi: 10.1016/S0168-9452(03)00077-3 CrossRefGoogle Scholar
  6. 6.
    Xiong FL, Sun XH, Gan L, Yang XL, Xu HB (2006) Puerarin protects rat pancreatic islets from damage by hydrogen peroxide. Eur J Pharmacol 529:1–7. doi: 10.1016/j.ejphar.2005.10.024 PubMedCrossRefGoogle Scholar
  7. 7.
    Lu XR, Gao E, Xu LZ, Li HZ, Kang B, Chen WN et al (1986) Blocking effect of puerarin on beta-adrenoceptors of isolated organs and the whole animal. Acta Pharmacol Sin 7:537–539Google Scholar
  8. 8.
    Cherdshewasart W, Sutjit W (2007) Correlation of antioxidant activity of major isoflavonoid contents of the phytoestrogen-rich Pueraria mirifica and Pueraria lobata. Phytomedicine 15:38–43. doi: 10.1016/j.phymed.2007.07.058 PubMedCrossRefGoogle Scholar
  9. 9.
    Guerra MC, Speroni E, Broccoli M, Cangini M, Pasini P, Minghett A et al (2000) Comparison between Chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin antioxidant properties and effect on rat liver CYP-catalyzed drug metabolism. Life Sci 67:2997–3006. doi: 10.1016/S0024-3205(00)00885-7 PubMedCrossRefGoogle Scholar
  10. 10.
    Benlhabib E, Baker JI, Keyler DE, Singh AK (2004) Effects of purified puerarin on voluntary alcohol intake and alcohol withdrawal symptoms in P rats receiving free access to water and alcohol. J Med Food 7:180–186. doi: 10.1089/1096620041224102 PubMedCrossRefGoogle Scholar
  11. 11.
    Lin RC, Guthrie S, Xie CY, Mai K, Lee DY, Lumeng L et al (1996) Isoflavonoid compounds extracts from Pueraria lobata suppress alcohol preference in a pharmacogenetic rat model of alcoholism. Alcohol Clin Exp Res 20:659–663. doi: 10.1111/j.1530-0277.1996.tb01668.x PubMedCrossRefGoogle Scholar
  12. 12.
    Keung WM, Vallee BL (1998) Kudzu root: an ancient Chinese source of modern antidipsotropic agents. Phytochemistry 47:499–506. doi: 10.1016/S0031-9422(97)00723-1 PubMedCrossRefGoogle Scholar
  13. 13.
    Chueh FS, Chang CP, Chio CC, Lin MT (2004) Puerarin acts through brain serotonergic mechanisms to induce thermal effects. J Pharmacol Sci 96:420–427. doi: 10.1254/jphs.FP0040424 PubMedCrossRefGoogle Scholar
  14. 14.
    Xuan B, Zhou YH, Yang RL, Li N, Min ZD, Chiou GC (1999) Improvement of ocular blood flow and retinal functions with puerarin analogs. J Ocul Pharmacol Ther 15:207–216PubMedCrossRefGoogle Scholar
  15. 15.
    Adamis AP, Miller JW, Bernal MT, D’Amico DJ, Folkman J, Yeo TK et al (1994) Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118:445–450PubMedGoogle Scholar
  16. 16.
    Dieudonné SC, La Heij EC, Diederen RM, Kessels AG, Liem AT, Kijlstra A et al (2007) Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy. Ophthalmic Res 39:148–154. doi: 10.1159/000103234 PubMedCrossRefGoogle Scholar
  17. 17.
    Zhang S, Chen S, Shen Y, Yang D, Liu X, Sun-chi AC et al (2006) Puerarin induces angiogenesis in myocardium of rat with myocardial infarction. Biol Pharm Bull 29:945–950. doi: 10.1248/bpb.29.945 PubMedCrossRefGoogle Scholar
  18. 18.
    Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD et al (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 9:4604–4613Google Scholar
  19. 19.
    Levy NS, Goldberg MA, Levy AP (1997) Sequencing of the human vascular endothelial growth factor (VEGF) 3′ untranslated region (UTR): conservation of five hypoxia-inducible RNA-protein binding sites. Biochim Biophys Acta 1352:167–173PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • Yan Teng
    • 1
  • Hao Cui
    • 1
  • Mingming Yang
    • 1
  • Han Song
    • 2
  • Qingsheng Zhang
    • 1
  • Ying Su
    • 1
  • Jianqiu Zheng
    • 1
  1. 1.Ophthalmology HospitalThe First Clinical College of Harbin Medical UniversityHarbinPeople’s Republic of China
  2. 2.Department of OphthalmologyHeilongjiang Province HospitalHarbinPeople’s Republic of China

Personalised recommendations